These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Mode of action and effects of botulinum neurotoxin A].
    Author: Périé S, Lacau St-Guily J.
    Journal: Ann Otolaryngol Chir Cervicofac; 1996; 113(2):73-8. PubMed ID: 8999747.
    Abstract:
    Intramuscular injection of botulinum neurotoxin A produces transitory blockade of neuromuscular transmission and inhibits presynaptic release of acetylcholine. Its action affects peripheral cholinergic receptors, which unlike central receptors, can render the toxin active by an internalization mechanism. The intracellular target of botulinum neurotoxin A is a protein of the acetylcholine vesicle membrane. Currently, indications of botulinum neurotoxin A are reserved solely for dystonia. Such treatment has been shown to be effective and tolerance is good; histological modifications (muscle atrophy, denervation and axonal sprouts) have been observed. The most frequently reported side effects are related to high doses and repeated injections of botulinum neurotoxin A.
    [Abstract] [Full Text] [Related] [New Search]